14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CNQQ vs TEST: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
TEST Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)
TEST Overall Winner
6-Pillar Tally: CNQQ 0 – 0 TEST (6 Tie)
Matrix Metrics: CNQQ 1 – 2 TEST
As of Nov 16, 2026, TEST (TEST) is the stronger overall head-to-head candidate over Rayliant-ChinaAMC Transformative China Tech ETF (CNQQ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CNQQ carries a Unified Composite Score of 41.2/100 (SELL) at $17.75 (N/M Forward P/E, N/A operating margin), whereas TEST carries 47.2/100 (HOLD) at $37.77 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: CNQQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.9); meanwhile TEST trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNQQ vs TEST. Trailing 12-month operating profitability (CNQQ N/A vs TEST N/A) and valuation multiples (CNQQ N/M vs TEST N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
TEST Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CNQQ vs TEST Key Questions & Quantitative Answers
As of Nov 16, 2026, TEST (TEST) is the stronger overall head-to-head candidate over Rayliant-ChinaAMC Transformative China Tech ETF (CNQQ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CNQQ carries a Unified Composite Score of 41.2/100 (SELL) at $17.75 (N/M Forward P/E, N/A operating margin), whereas TEST carries 47.2/100 (HOLD) at $37.77 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: CNQQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.9); meanwhile TEST trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CNQQ and TEST split Growth & Scale metrics: CNQQ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TEST at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CNQQ generates N/A in USD-normalized revenue versus N/A for TEST. In operating R&D and SG&A reinvestment, CNQQ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TEST.
CNQQ and TEST trade at balanced relative valuation multiples. CNQQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TEST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CNQQ (N/A ROE) versus TEST (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, CNQQ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 32% Vol realized risk). By comparison, TEST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.73β · 43% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.